Globus Medical, Inc.GMEDNYSE
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank72
3Y CAGR+48.6%
5Y CAGR-1.6%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+48.6%/yr
vs +128.7%/yr prior
5Y CAGR
-1.6%/yr
Recent acceleration
Acceleration
-80.2pp
Decelerating
Percentile
P72
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 18.21% |
| Q3 2025 | -41.35% |
| Q2 2025 | 168.81% |
| Q1 2025 | 184.71% |
| Q4 2024 | -48.87% |
| Q3 2024 | 63.21% |
| Q2 2024 | 546.26% |
| Q1 2024 | -147.34% |
| Q4 2023 | 1406.41% |
| Q3 2023 | -98.27% |
| Q2 2023 | 17.47% |
| Q1 2023 | -1.87% |
| Q4 2022 | 5.55% |
| Q3 2022 | -13.11% |
| Q2 2022 | 43.34% |
| Q1 2022 | 152.11% |
| Q4 2021 | -68.00% |
| Q3 2021 | 13.64% |
| Q2 2021 | -8.35% |
| Q1 2021 | -14.40% |
| Q4 2020 | 19.77% |
| Q3 2020 | 312.20% |
| Q2 2020 | -180.30% |
| Q1 2020 | -43.01% |
| Q4 2019 | 18.85% |
| Q3 2019 | 0.38% |
| Q2 2019 | 14.91% |
| Q1 2019 | -9.63% |
| Q4 2018 | 4.38% |
| Q3 2018 | -21.72% |
| Q2 2018 | 13.76% |
| Q1 2018 | 62.20% |
| Q4 2017 | -4.75% |
| Q3 2017 | -10.73% |
| Q2 2017 | -0.16% |
| Q1 2017 | 18.17% |
| Q4 2016 | -7.36% |
| Q3 2016 | 1.63% |
| Q2 2016 | -7.87% |
| Q1 2016 | -25.51% |